← Back to Patent Explorer
US4665054A Expired / Lapsed US ⏱️ 0.0 years remaining

Chemical derivatives of GHL-Cu

Assignee: BIOHEAL Inc A CORP OF WA
•
Filing: 1985-02-08
•
Granted: 1987-05-12
•
Expires: 2005-02-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Derivatives of GHL-Cu possessing greater resistance to proteolytic enzyme breakdown are disclosed. These derivatives can be tailored to increse their fat solubility, making them more useful in the formation of pharmaceutical creams and gels. Further, the derivatives of the present invention possess significant superoxide dismustase activity, making them useful for enhancing the wound-healing process in animals.

Inventors

  • 👤 Loren R. Pickart

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 20:00
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/30; A61K8/64; A61P; A61P29/00; A61P43/00; A61Q; A61Q7/00; C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0827; A61K2800/00; A61K2800/40; A61K2800/58; A61K38/00

Claims Analysis

Total Claims: 31
Claim 1
Independent Claim 77 words
Derivatives of GHL-Cu which possess wound-healing activity, said derivatives further possessing greater resistance to proteolytic enzyme breakdown, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR1## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 2
Dependent Claim 77 words
Derivatives of GHL-Cu which possess wound-healing activity, said derivatives further possessing greater resistance to proteolytic enzyme breakdown, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR1## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 3
Dependent Claim 13 words
The derivative of claim 1 wherein the aryl moiety is a benzyl moiety.
Claim 4
Dependent Claim 13 words
The derivative of claim 1 wherein the alkyl moiety is a methyl moiety.
Claim 5
Dependent Claim 13 words
The derivative of claim 1 wherein the alkyl moiety is an unbranched chain.
Claim 6
Dependent Claim 13 words
The derivative of claim 4 wherein the unbranched chain is an n-octyl moiety.
Claim 7
Independent Claim 87 words
A method for enhancing the wound-healing process in an animal, comprising administering to the animal a therapeutically effective amount of a composition containing a derivative of GHL-Cu, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR2## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 8
Independent Claim 87 words
A method for enhancing the wound-healing process in an animal, comprising administering to the animal a therapeutically effective amount of a composition containing a derivative of GHL-Cu, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR2## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 9
Dependent Claim 13 words
The method of claim 6 wherein the aryl moiety is a benzyl moiety.
Claim 10
Dependent Claim 13 words
The method of claim 6 wherein the alkyl moiety is a methyl moiety.
Claim 11
Dependent Claim 13 words
The method of claim 6 wherein the alkyl moiety is an unbranched chain.
Claim 12
Dependent Claim 13 words
The method of claim 9 wherein the unbranched chain is an n-octyl moiety.
Claim 13
Independent Claim 89 words
A method of inhibiting the production of thromboxane by platelets in animals comprising administering to the animal a therapeutically effective amount of a composition containing a derivative of GHL-Cu, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR3## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 14
Independent Claim 89 words
A method of inhibiting the production of thromboxane by platelets in animals comprising administering to the animal a therapeutically effective amount of a composition containing a derivative of GHL-Cu, said derivatives having the general formula: [glycyl-L-histidyl-L- ##STR3## copper (II) wherein R is selected from the group consisting of an NH 2 moiety, alkyl moieties containing from 1 to 12 carbon atoms, aryl moieties containing from 6 to 12 carbon atoms, alkoxy moieties containing from 1 to 12 carbon atoms, and aryloxy moieties containing from 6 to 12 carbon atoms.
Claim 15
Dependent Claim 13 words
The method of claim 11 wherein the aryl moiety is a benzyl moiety.
Claim 16
Dependent Claim 13 words
The method of claim 11 wherein the alkyl moiety is a methyl moiety.
Claim 17
Dependent Claim 13 words
The method of claim 11 wherein the alkyl moiety is an unbranched chain.
Claim 18
Dependent Claim 13 words
The derivative of claim 14 wherein the unbranched chain is an n-octyl moiety.
Claim 19
Dependent Claim 17 words
The derivative of claim 1 wherein said derivatives can be tailored to increase the fat solubility thereof.
Claim 20
Dependent Claim 13 words
The derivative of claim 1 wherein the aryloxy moiety is an O-benzyl moiety.
Claim 21
Dependent Claim 13 words
The derivative of claim 1 wherein the alkoxy moiety is a methoxy moiety.
Claim 22
Dependent Claim 17 words
The derivative of claim 1 wherein the carbon portion of the alkoxy moiety is an unbranched chain.
Claim 23
Dependent Claim 12 words
The derivative of claim 19 wherein the unbranched carbon chain is n-octyl.
Claim 24
Dependent Claim 13 words
The method of claim 6 wherein the aryloxy moiety is an O-benzyl moiety.
Claim 25
Dependent Claim 13 words
The method of claim 6 wherein the alkoxy moiety is a methoxy moiety.
Claim 26
Dependent Claim 17 words
The method of claim 6 wherein the carbon portion of the alkoxy moiety is an unbranched chain.
Claim 27
Dependent Claim 12 words
The method of claim 23 wherein the unbranched carbon chain is n-octyl.
Claim 28
Dependent Claim 13 words
The method of claim 11 wherein the aryloxy moiety is an O-benzyl moiety.
Claim 29
Dependent Claim 13 words
The method of claim 11 wherein the alkoxy moiety is a methoxy moiety.
Claim 30
Dependent Claim 17 words
The method of claim 11 wherein the carbon portion of the alkoxy moiety is an unbranched chain.
Claim 31
Dependent Claim 12 words
The method of claim 27 wherein the unbranched carbon chain is n-octyl.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-11 1990-11-10 1991-05-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-11 1994-11-10 1995-05-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-11 1998-11-10 1999-05-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag